AbbVie (ABBV) announced a multi-year partnership with McLaren Racing, naming it an Official Pharmaceutical Partner of the McLaren Mastercard Formula 1 Team. The AbbVie Race to Innovate campaign will donate $10,000 to global charities for every 10 Constructors' Championship points earned by McLaren, reflecting the ~10% of the global population affected by autoimmune diseases. The campaign launches at the 2026 United States Grand Prix in Austin and will expand through the 2027 season. Donations will support patient advocacy organizations serving people with immune-mediated diseases.
One free account opens every story complete, the live board, the 30-day calendar, a watchlist and breaking alerts on your phone. No card. The wire stays free to read.
